Infographics

Atypical EGFR mutations account for ~5–10% of EGFR mutations in NSCLC. See what community oncologists may be missing, from current options…

Can the perioperative approach in resectable G/GEJ adenocarcinoma be improved? MATTERHORN, a global Phase III trial, evaluated…

TOURMALINE evaluated the safety and efficacy of first-line durvalumab combined with one of seven gemcitabine-based chemotherapy regimens…

Chronic hand eczema (CHE) is common in the US and carries a significant humanistic impact. Drawing on the CHECK patient survey and RWEAL…

This infographic shows how DecisionDx-Melanoma fits into real clinical practice, translating three actionable risk prediction results into…

Oncology nurses support patients receiving targeted therapy by educating them on adverse event management. This infographic summarizes…

Treat-to-target care in systemic lupus erythematosus (SLE) focuses on defined goals like Definitions Of Remission In SLE (DORIS) remission…